ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Correction: to previous post. Apparently Scott Henry of Roth Capital did raise their price target to $73 from $65 after Q2 results. However it was not widely picked up. Only found it on The Fly, no other reporting agencies including MarketBeat.

Anip upgrade

Anip MarketBeat

Which brings into question a possible connection to the Roth meetings in both Boston and New York. September 27 & 28. (Why both locations?)